Michael Terrence Gibbs is CLO at T2 Biosystems, Inc. (TTOO). They have made 4 open-market trades across 1 company since 2017, most recently 2024-02-24.
CIK 0001665000
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $8K since 2017, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TTOO | 135 | $18 |
Shares reported on the most recent Form 4, priced at the 2024-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TTOO | SELL · 10b5-1 | 2023-03-28 | 2023-04-06 | $0.48 | $115 | -13.3% | -32.8% | -82.8% |
| TTOO | SELL · 10b5-1 | 2023-02-22 | 2023-03-09 | $0.62 | $2K | -9.6% | -24.3% | -85.8% |
| TTOO | BUY | 2022-04-07 | 2022-04-11 | $0.49 | $5K | -21.1% | -61.1% | -72.2% |
| TTOO | SELL · 10b5-1 | 2021-03-25 | 2021-03-25 | $1.56 | $14K | -6.0% | -14.5% | -25.9% |
| TTOO | SELL · 10b5-1 | 2021-02-23 | 2021-02-23 | $2.06 | $15K | -29.4% | -25.9% | -51.5% |
| TTOO | SELL · 10b5-1 | 2020-02-24 | 2020-02-25 | $0.82 | $5K | -25.2% | -10.9% | +5.0% |
| TTOO | SELL · 10b5-1 | 2020-02-11 | 2020-02-12 | $0.77 | $2K | -11.3% | -51.8% | -33.2% |
| TTOO | SELL · 10b5-1 | 2020-02-03 | 2020-02-05 | $0.88 | $3K | +15.8% | -40.8% | -37.3% |
| TTOO | SELL · 10b5-1 | 2019-02-11 | 2019-02-12 | $3.36 | $10K | +14.4% | -23.9% | -27.3% |
| TTOO | SELL | 2019-01-31 | 2019-02-05 | $3.43 | $9K | +1.1% | -14.0% | -21.1% |
| TTOO | SELL | 2018-02-09 | 2018-06-08 | $4.28 | $9K | -13.5% | -19.5% | -30.4% |
| TTOO | BUY | 2017-06-06 | 2017-06-08 | $3.51 | $4K | +8.3% | -10.5% | +39.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.